Consistent with what we previously reported (11), patients in the HMO-I group were characterized by severe hepatic and peripheral insulin resistance as well as overcompensated insulin secretion, which resulted in a balance and made the DI and glycosylated hemoglobin a1c (HbA1c) similar to the normal-weight controls. Here, INS is linked to Insulin resistance.